Thursday, 15 December 2022

Torrent Pharma inks with Boehringer Ingelheim to market anti-diabetics drug

Torrent Pharma inks with Boehringer Ingelheim to market anti-diabetics drug
Torrent Pharma inks with Boehringer Ingelheim to market anti-diabetics drug
Pradip Mahajan Thu, 12/15/2022 - 15:49

Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited (BI India) to co-market Cospiaq (Empagliflozin), Cospiaq MetTM (Empagliflozin+ Metformin) and Xilingio  (Empagliflozin+ Linagliptin) in India.



source https://www.pharmatutor.org/pharma-news/2022/torrent-pharma-inks-with-boehringer-ingelheim-to-market-anti-diabetics
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Career for Pharmacy and Biotech at National Agri-Food and Biomanufacturing Institute

Positions: Junior Research Fellow (JRF) (One) Master’s Degree from a recognized University/Institute in M.Sc. Chemistry - Organic / Physical...